Kestra Advisory Services, LLC Bei Gene, Ltd. Transaction History

Kestra Advisory Services, LLC

$17.3 Billion
Q3 2024

A detailed history of Kestra Advisory Services, LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 1,434 shares of BGNE stock, worth $313,615. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,434

Previous 1,555 7.78%

Holding current value

$313,615

Previous $221,000 45.25%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$143.93 - $224.51 $17,415 - $27,165	-121 Reduced 7.78%	1,434 $321,000
Q2 2024 Aug 14, 2024	SELL	$129.52 - $174.32 $2,072 - $2,789	-16 Reduced 1.02%	1,555 $221,000
Q1 2024 May 15, 2024	BUY	$141.8 - $181.47 $15,598 - $19,961	110 Added 7.53%	1,571 $245,000
Q4 2023 Feb 14, 2024	SELL	$158.67 - $201.58 $317 - $403	-2 Reduced 0.14%	1,461 $263,000
Q3 2023 Nov 09, 2023	BUY	$179.87 - $225.13 $39,751 - $49,753	221 Added 17.79%	1,463 $263,000
Q2 2023 Aug 11, 2023	SELL	$178.3 - $266.78 $53,311 - $79,767	-299 Reduced 19.4%	1,242 $221,000
Q1 2023 May 12, 2023	SELL	$215.53 - $274.5 $235,358 - $299,754	-1,092 Reduced 41.47%	1,541 $332,000
Q4 2022 Jan 31, 2023	BUY	$125.51 - $229.3 $38,029 - $69,477	303 Added 13.0%	2,633 $579,000
Q3 2022 Nov 01, 2022	BUY	$131.8 - $202.24 $4,876 - $7,482	37 Added 1.61%	2,330 $314 Million
Q2 2022 Aug 12, 2022	BUY	$121.11 - $216.05 $6,055 - $10,802	50 Added 2.23%	2,293 $371,000
Q1 2022 Apr 26, 2022	BUY	$146.52 - $269.56 $32,527 - $59,842	222 Added 10.98%	2,243 $423,000
Q4 2021 Jan 20, 2022	SELL	$248.56 - $389.34 $20,879 - $32,704	-84 Reduced 3.99%	2,021 $547,000
Q3 2021 Oct 19, 2021	BUY	$249.6 - $403.14 $14,726 - $23,785	59 Added 2.88%	2,105 $764,000
Q2 2021 Jul 28, 2021	BUY	$292.75 - $367.01 $38,935 - $48,812	133 Added 6.95%	2,046 $702,000
Q1 2021 May 10, 2021	BUY	$260.64 - $382.12 $179,580 - $263,280	689 Added 56.29%	1,913 $665,000
Q4 2020 Jan 20, 2021	BUY	$221.31 - $316.61 $267,342 - $382,464	1,208 Added 7550.0%	1,224 $312 Million
Q3 2020 Nov 12, 2020	BUY	$189.18 - $286.44 $3,026 - $4,583	16 New	16 $358 Million

Others Institutions Holding BGNE

# of Institutions

253

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $22.7B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Account

Kestra Advisory Services, LLC Bei Gene, Ltd. Transaction History